Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Chizuko, Hashimoto"'
Autor:
Ritsuro Suzuki, Kazuo Oshimi, Keisei Kawa, Shigeo Nakamura, Rie Hyo, Junji Suzumiya, Motoko Yamaguchi, Hikaru Kobayashi, Seiichi Okamura, Hajime Kobayashi, Yuichi Hasegawa, Jun Takizawa, Yasushi Isobe, Noriyasu Fukushima, Koji Izutsu, Fumihiro Ishida, Chizuko Hashimoto, Yoshinobu Maeda, Hiroshi Kimura, Yoshinori Ito
Purpose: Extranodal NK/T-cell lymphoma, nasal type (ENKL) is an Epstein–Barr virus (EBV)–associated lymphoma for which a new chemotherapeutic regimen called SMILE (steroid, methotrexate, ifosfamide, l-asparaginase, and etoposide) recently showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496b56e432d8d4fb61c7ab86c384150d
https://doi.org/10.1158/1078-0432.c.6520874.v1
https://doi.org/10.1158/1078-0432.c.6520874.v1
Autor:
Ritsuro Suzuki, Kazuo Oshimi, Keisei Kawa, Shigeo Nakamura, Rie Hyo, Junji Suzumiya, Motoko Yamaguchi, Hikaru Kobayashi, Seiichi Okamura, Hajime Kobayashi, Yuichi Hasegawa, Jun Takizawa, Yasushi Isobe, Noriyasu Fukushima, Koji Izutsu, Fumihiro Ishida, Chizuko Hashimoto, Yoshinobu Maeda, Hiroshi Kimura, Yoshinori Ito
PDF file - 64K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a41a34360ee3b4bd6e0e7781b09b6e8
https://doi.org/10.1158/1078-0432.22446782
https://doi.org/10.1158/1078-0432.22446782
Autor:
Ritsuro Suzuki, Kazuo Oshimi, Keisei Kawa, Shigeo Nakamura, Rie Hyo, Junji Suzumiya, Motoko Yamaguchi, Hikaru Kobayashi, Seiichi Okamura, Hajime Kobayashi, Yuichi Hasegawa, Jun Takizawa, Yasushi Isobe, Noriyasu Fukushima, Koji Izutsu, Fumihiro Ishida, Chizuko Hashimoto, Yoshinobu Maeda, Hiroshi Kimura, Yoshinori Ito
PDF file - 86K, 4.Correlation of EBER positivity and EBV-DNA levels in whole blood or plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb4249692075dc6d904f7f838774233
https://doi.org/10.1158/1078-0432.22446785.v1
https://doi.org/10.1158/1078-0432.22446785.v1
Autor:
Masahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, Yusuke Saigusa, Takaaki Takeda, Yuto Hibino, Mayumi Tokunaga, Takuma Ohashi, Ayako Matsumura, Haruka Teshigawara, Taisei Suzuki, Hiroshi Teranaka, Yuki Nakajima, Kenji Matsumoto, Chizuko Hashimoto, Katsumichi Fujimaki, Hiroyuki Fujita, Rika Sakai, Shin Fujisawa, Hideaki Nakajima
Publikováno v:
Blood. 140:3809-3810
Autor:
Kazuho Miyashita, Ayumi Numata, Jun Taguchi, Hideyuki Koharazawa, Takayuki Sakuma, Yoshimi Ishii, Rika Sakai, Yuki Nakajima, Katsumichi Fujimaki, Takuya Miyazaki, Hideaki Nakajima, Hiroyuki Takahashi, Hiroyuki Fujita, Yukako Hattori, Chizuko Hashimoto, Ayako Matsumura, Sachiya Takemura
Publikováno v:
Indian J Hematol Blood Transfus
We performed a retrospective analysis of DLBCL with breast involvement to compare the prognosis of primary breast lymphoma (PBL) to secondary breast lymphoma (SBL; especially in limited stage cases). We retrospectively reviewed records of 25 diffuse
Autor:
Rumiko Okamoto, Kazutaka Sunami, Rishu Takimoto, Yukiyoshi Moriuchi, Kayoko Murayama, Ayumi Numata, Reina Watanabe, Masahiro Yokoyama, Yutaka Shimazu, Hirohiko Shibayama, Yasufumi Masaki, Kazuya Sato, Naoto Tomita, Masahide Yamamoto, Takahiro Yano, Hiromichi Takahashi, Ako Kikuchi, Kengo Takeuchi, Ikuo Miura, Chizuko Hashimoto, Wataru Yamamoto, Kazuo Tamura, Saburo Tsunoda, Rika Ohshima, Hideaki Nakajima, Tomohiro Kinoshita
Publikováno v:
Leukemia & Lymphoma. 59:97-104
Central nervous system (CNS) involvement is a serious complication in patients with diffuse large B-cell lymphoma (DLBCL) and evaluating CNS risk is an important issue. Using the standard international prognostic index (IPI) and CNS-IPI, a recently p
Autor:
Masatsugu Tanaka, Hideyuki Koharazawa, Kenji Motohashi, Chizuko Hashimoto, Kenji Matsumoto, Heiwa Kanamori, Maki Hagihara, Katsumichi Fujimaki, Hideaki Nakajima, Etsuko Yamazaki, Wataru Yamamoto, Eriko Ogusa, Shin Fujisawa, Yoshimi Ishii, Takayoshi Tachibana, Taiki Ando, Jun Taguchi, Hiroyuki Fujita
Publikováno v:
International Journal of Hematology. 105:623-630
Body mass index (BMI), which represents the proportion of weight to height, is a controversial prognostic factor for acute myeloid leukemia (AML). We evaluated prognostic value of BMI in Japanese AML. The study included 369 adult patients with newly
Autor:
Shin Fujisawa, Rika Kawasaki, Yuki Nakajima, D. Ishibashi, R. Watanabe, Sachiya Takemura, Hirotaka Takasaki, Hideyuki Koharazawa, Naoto Tomita, Kenji Motohashi, Chizuko Hashimoto, Satoshi Koyama, Rika Sakai, Yoshimi Ishii, Yutaka Hattori, Etsuko Yamazaki, S. Motomura, Megumi Itabashi, Hideaki Nakajima
Publikováno v:
International Journal of Laboratory Hematology. 39:112-117
SummaryIntroduction The prognostic value of serum ferritin level in patients with peripheral T-cell lymphoma (PTCL) remains unknown. Methods We retrospectively analyzed clinical data from 78 consecutive patients with newly diagnosed PTCL that were tr
Autor:
Hideaki Nakajima, Haruka Teshigawara, Etsuko Yamazaki, Kenji Motohashi, Takuya Miyazaki, Hiroyuki Fujita, Masatsugu Tanaka, Hideyuki Koharazawa, Taiki Ando, Chizuko Hashimoto, Eriko Ogusa, Katsumichi Fujimaki, Kenji Matsumoto, Kazuho Miyashita, Yoshimi Ishii, Takayoshi Tachibana, Jun Taguchi, Shin Fujisawa, Heiwa Kanamori, Maki Hagihara
Publikováno v:
International journal of hematology. 109(6)
We hypothesized that treatment-related weight loss is associated with worse outcomes following HSCT. Overall, 184 patients with AML who underwent induction therapy were classified according to d-BMI (BMI at transplant minus BMI at diagnosis) (kg/m2)
Autor:
Masataka Taguri, Yukako Hattori, Wataru Yamamoto, Chizuko Hashimoto, Yoshimi Ishii, Takuya Miyazaki, Hirotaka Takasaki, Takayoshi Tachibana, Katsumichi Fujimaki, Naoto Tomita, Yoshiaki Ishigatsubo, Taisei Suzuki, Yuki Nakajima, Yasufumi Ishiyama, Rika Sakai, Etsuko Yamazaki, Kazuho Miyashita, Kenji Matsumoto, Shigeki Motomura, Sachiya Takemura, Ayumi Numata
Publikováno v:
Leukemia Research. 39:1187-1191
Useful prognostic markers for patients with diffuse large B cell lymphoma (DLBCL) have been reported. To identify which biomarker best predicts the prognosis of patients with DLBCL, we performed a retrospective study that included 319 DLBCL patients